A detailed history of Black Rock Inc. transactions in Mannkind Corp stock. As of the latest transaction made, Black Rock Inc. holds 21,627,095 shares of MNKD stock, worth $113 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,627,095
Previous 22,297,032 3.0%
Holding current value
$113 Million
Previous $81.2 Million 20.71%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$3.25 - $5.27 $2.18 Million - $3.53 Million
-669,937 Reduced 3.0%
21,627,095 $98 Million
Q4 2023

Feb 13, 2024

BUY
$3.34 - $4.29 $5.88 Million - $7.55 Million
1,759,771 Added 8.57%
22,297,032 $81.2 Million
Q3 2023

Nov 13, 2023

SELL
$3.91 - $5.45 $129,155 - $180,024
-33,032 Reduced 0.16%
20,537,261 $84.8 Million
Q2 2023

Aug 11, 2023

SELL
$3.72 - $4.79 $420,575 - $541,547
-113,058 Reduced 0.55%
20,570,293 $83.7 Million
Q1 2023

May 12, 2023

SELL
$3.95 - $5.63 $1.29 Million - $1.83 Million
-325,444 Reduced 1.55%
20,683,351 $84.8 Million
Q4 2022

Feb 13, 2023

BUY
$3.02 - $5.37 $2.24 Million - $3.98 Million
740,704 Added 3.65%
21,008,795 $111 Million
Q3 2022

Nov 14, 2022

SELL
$2.99 - $4.35 $3.06 Million - $4.45 Million
-1,022,862 Reduced 4.8%
20,268,091 $62.6 Million
Q2 2022

Aug 12, 2022

BUY
$2.67 - $4.77 $1.49 Million - $2.66 Million
557,229 Added 2.69%
21,290,953 $81.1 Million
Q1 2022

May 12, 2022

SELL
$2.62 - $4.45 $680,592 - $1.16 Million
-259,768 Reduced 1.24%
20,733,724 $76.3 Million
Q4 2021

Feb 10, 2022

SELL
$4.05 - $5.37 $2.73 Million - $3.62 Million
-674,958 Reduced 3.11%
20,993,492 $91.7 Million
Q3 2021

Nov 09, 2021

SELL
$3.89 - $5.48 $830,635 - $1.17 Million
-213,531 Reduced 0.98%
21,668,450 $94.3 Million
Q2 2021

Aug 11, 2021

BUY
$3.61 - $5.45 $79 Million - $119 Million
21,881,981 New
21,881,981 $119 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.34B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.